申请人:GLAXO GROUP LTD
公开号:WO2003087088A2
公开(公告)日:2003-10-23
Compounds of formula (I): are inhibitors of the enzyme Lp-PLA2 and are of use in therapy, in particular for treating atherosclerosis. In Formula (I) R1, R2, R3, R4, R5, R6, X and Y are as defined herein.